PT854724E - Metodo de tratar a doenca navicular em cavalos - Google Patents

Metodo de tratar a doenca navicular em cavalos

Info

Publication number
PT854724E
PT854724E PT96933368T PT96933368T PT854724E PT 854724 E PT854724 E PT 854724E PT 96933368 T PT96933368 T PT 96933368T PT 96933368 T PT96933368 T PT 96933368T PT 854724 E PT854724 E PT 854724E
Authority
PT
Portugal
Prior art keywords
treating
navicular disease
horses
pct
compound
Prior art date
Application number
PT96933368T
Other languages
English (en)
Inventor
Jonathan Green
Alan Martin Wilson
Allen Edward Goodship
Original Assignee
Novartis Ag
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4241002&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT854724(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag, Novartis Pharma Gmbh filed Critical Novartis Ag
Publication of PT854724E publication Critical patent/PT854724E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT96933368T 1995-09-29 1996-09-24 Metodo de tratar a doenca navicular em cavalos PT854724E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH276095 1995-09-29

Publications (1)

Publication Number Publication Date
PT854724E true PT854724E (pt) 2005-08-31

Family

ID=4241002

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96933368T PT854724E (pt) 1995-09-29 1996-09-24 Metodo de tratar a doenca navicular em cavalos

Country Status (9)

Country Link
US (1) US6057306A (pt)
EP (1) EP0854724B1 (pt)
JP (1) JPH11513383A (pt)
AT (1) ATE290871T1 (pt)
AU (1) AU7213196A (pt)
DE (1) DE69634487T2 (pt)
ES (1) ES2239774T3 (pt)
PT (1) PT854724E (pt)
WO (1) WO1997012619A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2784031B1 (fr) * 1998-10-02 2002-02-01 Sanofi Elf Utilisation de derives de l'acide bisphosphonique pour la preparation d'un medicament destine au traitement des boiteries
US6794536B1 (en) * 1998-12-10 2004-09-21 Aesqen, Inc. Method for preparation of disodium pamidronate
ATE304856T1 (de) 2000-06-20 2005-10-15 Novartis Pharma Gmbh Methode zur verabreichung von biphosphonaten
US6638920B2 (en) * 2000-07-21 2003-10-28 Merck & Co., Inc. Compositions and methods of preventing or reducing the risk or incidence of skeletal injuries in horses
CA2372450A1 (en) * 2001-05-10 2001-09-19 Pharmaceutical Partners Of Canada Inc. Liquid injectable formulation of disodium pamidronate
WO2003070169A2 (en) * 2002-02-19 2003-08-28 Ilex Products, Inc. Aminodiphosphonate apolipoprotein e modulators
WO2008128056A1 (en) * 2004-10-08 2008-10-23 The Board Of Trustees Of The University Of Illinois Bisphosphonate compounds and methods with enhanced potency for multiple targets including fpps, ggpps, and dpps
US7358361B2 (en) 2004-10-08 2008-04-15 The Board Of Trustees Of The University Of Illinois Biophosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases
DE102005053512A1 (de) * 2005-11-09 2007-06-28 Omnimedic Gbr Verwendung von Clodronsäure zur Behandlung von Podotrochlose
KR20080111070A (ko) * 2006-03-17 2008-12-22 더 보오드 오브 트러스티스 오브 더 유니버시티 오브 일리노이즈 비스포스포네이트 화합물 및 방법
FR2926081B1 (fr) * 2008-01-03 2010-02-19 Univ Nantes Derives d'acide hydroxy-bisphosphonique comme vecteur ciblant le tissu osseux
US20110118243A1 (en) * 2008-03-20 2011-05-19 Lynn Chambers Anti-inflammatory drug delivery system
CN105924470B (zh) * 2016-07-11 2019-01-29 成都云克药业有限责任公司 一种二膦酸化合物及其制备方法与应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2130794C3 (de) * 1971-06-22 1974-07-11 Joh. A. Benckiser Gmbh, 6700 Ludwigshafen Verfahren zur Herstellung von l-Hydroxy-S-amino-propan-ljl-diphosphonsäure
DE2405254C2 (de) * 1974-02-04 1982-05-27 Henkel KGaA, 4000 Düsseldorf Verwendung von 3-Amino-1-Hydroxypropan-1, 1-diphosphonsäure oder ihrer wasserlöslichen Salze bei der Beeinflußung von Calciumstoffwechselstörungen im menschlichen oder tierischen Körper
SE7612534L (sv) * 1975-12-01 1977-06-02 Henkel & Cie Gmbh Forfarande for framstellning av farmaceutiska preparat for behandling av storningar i kalciumemnesomsettning
FR2531088B1 (fr) * 1982-07-29 1987-08-28 Sanofi Sa Produits anti-inflammatoires derives de l'acide methylenediphosphonique et leur procede de preparation
DE3428524A1 (de) * 1984-08-02 1986-02-13 Boehringer Mannheim Gmbh, 6800 Mannheim Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
ES2039237T3 (es) * 1986-04-24 1993-09-16 Fujisawa Pharmaceutical Co., Ltd. Procedimiento para preparar nuevos compuestos de acido difosfonico.
DE3623397A1 (de) * 1986-07-11 1988-01-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
DE3776880D1 (de) * 1986-11-21 1992-04-02 Ciba Geigy Ag Neue substituierte alkandiphosphonsaeuren.
EP0274346B1 (de) * 1986-11-21 1991-03-06 Ciba-Geigy Ag Neue Substituiertaminomethandiphosphonsäuren
US5057505A (en) * 1986-11-21 1991-10-15 Ciba-Geigy Corporation Substituted aminomethanediphosphonic acids and use in medicaments
IE912115A1 (en) * 1990-06-25 1992-01-01 Takeda Chemical Industries Ltd Bisphosphonic acid derivatives, their production and use

Also Published As

Publication number Publication date
WO1997012619A1 (en) 1997-04-10
EP0854724B1 (en) 2005-03-16
ATE290871T1 (de) 2005-04-15
EP0854724A1 (en) 1998-07-29
JPH11513383A (ja) 1999-11-16
DE69634487T2 (de) 2006-01-05
AU7213196A (en) 1997-04-28
US6057306A (en) 2000-05-02
DE69634487D1 (de) 2005-04-21
ES2239774T3 (es) 2005-10-01

Similar Documents

Publication Publication Date Title
ES2173172T3 (es) Derivados de 1,3-dihidroindol-2-ona sustituidos en 3 por un grupo nitrogenado como agonistas y/o antagonistas de la vasopresina y/o de la octocina.
DE69418461D1 (de) Neue 5-pyrrolyl-2-pyridylmethylsulfinyl benzimidazol-derivate
FI971967A0 (fi) Dioksomorfoliinien käyttö sisäloisten torjuntaan, uusia dioksomorfiineja ja menetelmä niiden valmistamiseksi
PT854724E (pt) Metodo de tratar a doenca navicular em cavalos
BR9609888A (pt) Halogenobenzimidazóis
GB9408577D0 (en) New compound
BR9909844A (pt) Processo para sintetizar um composto, e, composto.
DE69512930D1 (de) Stilben-derivate verwendbar als cyclooxygenase-2 hemmer
DE69534120D1 (de) Topisch anzuwendende ketoconazol enthaltende emulsionen
FI970147A0 (fi) Triatsoliyhdisteitä ja niiden käyttö dopamiini-D3-ligandeina
BR9508295A (pt) Utilização de compostos de tiazol e tiadiazol composto composição farmacêutica e processos para preparar um composto e tratar distúrbios que respondem a ligantes de receptor d3 de dopamina
DE69431601D1 (de) Neue verwendung von dexmedetomidin
ES2135769T3 (es) Derivados de isotiourea como inhibidores de no-sintasa.
ATE123773T1 (de) 1,3,5-triazin-2,4,6-tris- alkylaminocarbonsäureaminoester, diese enthaltende biozide mittel sowie verfahren zu ihrer herstellung.
ATE159511T1 (de) Derivate von n,n,n',n'-tetrasubstituierten 1,2- ethylendiamin-verbindungen
KR960702456A (ko) 4-(p-플로오로페닐)-3-[(3,4-(메틸렌디옥시)페녹시)메틸]피페리딘의 n-p-할로벤조일메틸 유도체(n-p-halobenzoylmethyl derivatives of 4-(p-fluorophenyl)-3-[[3,4-(methylenedioxy)phenoxy]methyl]piperidine)
ES2137665T3 (es) Nuevos derivados de piridina o piridazina, procedimientos para su preparacion, y medicamentos que contienen estos compuestos.
NO971325L (no) Fremgangsmåte for fremstilling av 3,4-dihydroksy-5-nitrobenzaldehyd
SE9404438D0 (sv) New process
RU94013445A (ru) Новое соединение, лейстродуксин н, способ его получения и терапевтическая композиция